Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04121039 | Study of the Apatinib Combine With POF Versus POF in Gastric Cancer | unknown | Phase 2 | 116 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 9, 2019 | clinicaltrials |
| NCT04089657 | Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens(ASGARD) | unknown | Phase 2 | 40 | Fujian Cancer HospitalOTHER_GOV | 0 | Sep 13, 2019 | clinicaltrials |
| NCT03263741 | Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer | unknown | Phase 2 | 20 | Affiliated Hospital of Qinghai UniversityOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT03829345 | A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer(SOLAR) | unknown | Phase 2 | 54 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT03229096 | Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer | unknown | Phase 2 | 35 | Shanghai Zhongshan HospitalOTHER | 1 | Jun 28, 2019 | clinicaltrials |
| NCT04001569 | AZD8186 and Paclitaxel in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 49 | Seoul National University Bundang HospitalOTHER | 1 | Jun 28, 2019 | clinicaltrials |
| NCT03990103 | S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites | unknown | Phase 2 | 66 | China Medical University, ChinaOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT03966118 | Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma(AIO-STO-0218) | unknown | Phase 2 | 59 | P. C. Thuss-PatienceOTHER | 1 | Jun 3, 2019 | clinicaltrials |
| NCT03954756 | Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer | unknown | Phase 2 | 35 | Henan Cancer HospitalOTHER_GOV | 0 | May 17, 2019 | clinicaltrials |
| NCT03817411 | Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer | unknown | Phase 2 | 90 | Taizhou EOC Pharma Co., Ltd.INDUSTRY | 1 | May 7, 2019 | clinicaltrials |
| NCT03694977 | Biomarker Study of PDR001 in Combination With MCS110 in Gastric Cancer | unknown | Phase 2 | 30 | Seoul National University HospitalOTHER | 1 | Apr 9, 2019 | clinicaltrials |
| NCT02007148 | MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer(MICADO) | unknown | Phase 2 | 51 | International Group of Endovascular OncologyOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02486601 | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma(FOXAGAST) | unknown | Phase 2 | 55 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT03837301 | Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) | unknown | Phase 2 | 88 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 12, 2019 | clinicaltrials |
| NCT02697838 | Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer | unknown | Phase 2 | 20 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 17, 2018 | clinicaltrials |
| NCT03701373 | Maintenance Treatment With S-1 in Gastric Cancer Patients | unknown | Phase 2 | 200 | Sun Yat-sen UniversityOTHER | 1 | Oct 10, 2018 | clinicaltrials |
| NCT02404753 | A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy(REALIZATION) | unknown | Phase 2 | 102 | Peking UniversityOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT03564834 | Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients | unknown | Phase 2 | 180 | Peking UniversityOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT03599778 | XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma | unknown | Phase 1 / Phase 2 | 52 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03575637 | Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer | unknown | Phase 2 | 180 | Peking UniversityOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT02596256 | Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301) | unknown | Phase 2 | 80 | Chinese PLA General HospitalOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02942329 | Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03427684 | Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 18 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 9, 2018 | clinicaltrials |
| NCT03428425 | A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 | 38 | Hebei Medical UniversityOTHER | 0 | Feb 9, 2018 | clinicaltrials |
| NCT03410732 | Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer | unknown | Phase 2 | 120 | LanZhou UniversityOTHER | 1 | Jan 25, 2018 | clinicaltrials |
| NCT03399253 | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor | unknown | Phase 2 / Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT03392103 | Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection | unknown | Phase 2 | 48 | Zhongnan HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT02461407 | Study of Anlotinib in Patients With Gastric Cancer(ALTER0503) | unknown | Phase 2 / Phase 3 | 378 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 29, 2017 | clinicaltrials |
| NCT02509806 | Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02510469 | Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells | unknown | Phase 2 / Phase 3 | 48 | Hebei Medical UniversityOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03007446 | The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer | unknown | Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT03271073 | A Study of Apatinib Combined With S1 in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 20 | Beijing Friendship HospitalOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03258034 | A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer | unknown | Phase 2 | 50 | The First Affiliated Hospital of Zhejiang Chinese Medical UniversityOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT01406249 | XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 100 | Epidemiological and Clinical Research Information NetworkOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT01412294 | XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer | unknown | Phase 2 | 40 | Epidemiological and Clinical Research Information NetworkOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| NCT03144843 | Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | unknown | Phase 2 | 110 | Sun Yat-sen UniversityOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT03137004 | Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 47 | Fujian Cancer HospitalOTHER_GOV | 1 | May 8, 2017 | clinicaltrials |
| NCT03044743 | PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | unknown | Phase 1 / Phase 2 | 20 | Yang YangOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT02711033 | Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection | unknown | Phase 2 | 144 | Guangdong Provincial Hospital of Traditional Chinese MedicineOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02694081 | The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric | unknown | Phase 2 | 100 | Jilin UniversityOTHER | 1 | Jan 2, 2017 | clinicaltrials |
| NCT02976142 | The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer | unknown | Phase 2 | 150 | Moscow Clinical Scientific CenterOTHER | 0 | Dec 13, 2016 | clinicaltrials |
| NCT02617134 | CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT01504997 | Phase II Study for Robot Assisted Distal Gastrectomy(RADGphaseII) | unknown | Phase 2 | 23 | Shizuoka Cancer CenterOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT02949258 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer(NCT-B4) | unknown | Phase 2 | 40 | Jinling Hospital, ChinaOTHER | 1 | Oct 31, 2016 | clinicaltrials |
| NCT02873520 | Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 40 | Ningbo Cancer HospitalINDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02644148 | Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients | unknown | Phase 2 | 150 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT02855788 | Metronomic Chemotherapy in Advanced Gastric Cancer | unknown | Phase 2 | 40 | Huashan HospitalOTHER | 2 | Aug 4, 2016 | clinicaltrials |
| NCT02529878 | Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital of Zhejiang Chinese Medical UniversityOTHER | 1 | Jul 26, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Oct 9, 2019source: clinicaltrials